Related Experiment Video
Updated: May 10, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
Adult severe community-acquired pneumonia with bloodstream infection caused by ψUSA 300: A case report
Shinichi Morimoto1, Mituhiro Kamada2, Yuka Motomura3
1Department of Emergency and Critical Care Medicine, Faculty of Medicine, Fukuoka University, Fukuoka 814-0180, Japan.
Abstract:
We report the first case of fatal community-acquired pneumonia with concomitant bloodstream infection caused by the ψUSA300 strain of methicillin-resistant Staphylococcus aureus (MRSA). The isolate was positive for Panton-Valentine leukocidin (PVL) gene, with a unique 12-base pair deletion in the ccrB2 gene, differentiating it from the canonical USA300 strain. Despite aggressive therapeutic interventions, the patient developed multiple complications, including septic shock, which ultimately proved fatal. Genetic sequencing confirmed the presence of the ψUSA300 strain.
Insights
This study details a fatal case of community-acquired pneumonia and bloodstream infection caused by a novel methicillin-resistant Staphylococcus aureus (MRSA) strain, designated ψUSA300. This unique MRSA strain, positive for the Panton-Valentine leukocidin (PVL) gene, led to a fatal outcome despite intensive treatment.
Area of Science:
- Infectious Diseases
- Microbiology
- Genetics
Background:
- Community-acquired pneumonia (CAP) can be severe and life-threatening.
- Methicillin-resistant Staphylococcus aureus (MRSA) is a significant pathogen causing both hospital-acquired and community-acquired infections.
- Certain MRSA strains, like USA300, are associated with severe disease due to specific virulence factors.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
03:22Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Atypical Pneumonia
Clinical Significance of Antibiotic Resistance
Pneumonia I: Introduction